Qingdao Haier Biomedical Co Ltd
SSE:688139
Relative Value
The Relative Value of one
Qingdao Haier Biomedical Co Ltd
stock under the Base Case scenario is
26.28
CNY.
Compared to the current market price of 32.5 CNY,
Qingdao Haier Biomedical Co Ltd
is
Overvalued by 19%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Qingdao Haier Biomedical Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Qingdao Haier Biomedical Co Ltd
SSE:688139
|
10.3B CNY | 4.6 | 40.4 | 45.2 | 45.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
188.2B USD | 4.3 | 29 | 16.4 | 22.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170.3B USD | 16.9 | 59.7 | 45.5 | 55 | |
| US |
|
Stryker Corp
NYSE:SYK
|
138B USD | 5.6 | 43.3 | 22 | 26.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
135.8B USD | 6 | 41.7 | 24.7 | 33.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
133.6B USD | 3.8 | 27.8 | 15.5 | 22.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58.9B USD | 2.8 | 36 | 13.1 | 22.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.2B EUR | 2.1 | 22.6 | 12.7 | 18 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.6B USD | 12.2 | 49.3 | 35.5 | 39.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.7B USD | 8.1 | 34.7 | 24.7 | 27.1 | |
| US |
|
Resmed Inc
NYSE:RMD
|
37.3B USD | 7.1 | 25.7 | 18.2 | 20.2 |